Ondokuz Mayis Univ. Med. Fac.; Neurology
About Ondokuz Mayis Univ. Med. Fac.; Neurology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
Clinical Trials at Ondokuz Mayis Univ. Med. Fac.; Neurology
During the past decade, Ondokuz Mayis Univ. Med. Fac.; Neurology conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-09-20
2022-12-30
Completed
835
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
2017-03-29
2019-06-11
Terminated
806
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-08-22
2022-11-28
Terminated
982
An Open-Label Crenezumab Study in Participants With Alzheimer's Disease
2018-04-11
2019-05-31
Terminated
149
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)
2021-02-01
2023-03-06
Terminated
1,379
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ondokuz Mayis Univ. Med. Fac.; Neurology"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Ondokuz Mayis Univ. Med. Fac.; Neurology
According to Clinical.Site data, the most researched conditions in "Ondokuz Mayis Univ. Med. Fac.; Neurology" are
"Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials) and "Generalized Myasthenia Gravis" (1 trials). Many other conditions were trialed in "Ondokuz Mayis Univ. Med. Fac.; Neurology" in a lesser frequency.
Clinical Trials Intervention Types at Ondokuz Mayis Univ. Med. Fac.; Neurology
Most popular intervention types in "Ondokuz Mayis Univ. Med. Fac.; Neurology" are "Drug" (10 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (6 trials), "Placebo" (3 trials), "Crenezumab" (2 trials), "Gantenerumab" (2 trials) and "Fenebrutinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ondokuz Mayis Univ. Med. Fac.; Neurology
The vast majority of trials in "Ondokuz Mayis Univ. Med. Fac.; Neurology" are
11 trials for "All" genders.
Clinical Trials Status at Ondokuz Mayis Univ. Med. Fac.; Neurology
Currently, there are NaN active trials in "Ondokuz Mayis Univ. Med. Fac.; Neurology".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Ondokuz Mayis Univ. Med. Fac.; Neurology,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Ondokuz Mayis Univ. Med. Fac.; Neurology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".